Similar Articles
-
Reinitiating Warfarin: Relationships Between Dose and Selected Patient, Clinical and Hospital Measures
Lucas G Leonhard, Richard L Berg, James K Burmester, Joseph J Mazza, John R Schmelzer and Steven H Yale- Clinical Medicine & Research June 2014, cmr.2014.1208;
- DOI: https://doi.org/10.3121/cmr.2014.1208
-
Reinitiating Warfarin: Relationships Between Dose and Selected Patient, Clinical and Hospital Measures
Lucas G. Leonhard, Richard L. Berg, James K. Burmester, Joseph J. Mazza, John R. Schmelzer and Steven H. Yale- Clinical Medicine & Research March 2015, 13 (1) 1;
- DOI: https://doi.org/10.3121/cmr.2014.1208
-
Initiation of Warfarin in Hospitals
Suhail A.R. Doi- Clinical Medicine & Research December 2007, 5 (4) 207;
- DOI: https://doi.org/10.3121/cmr.2007.777
-
Evaluation of Genetic Factors for Warfarin Dose Prediction
Michael D. Caldwell, Richard L. Berg, Kai Qi Zhang, Ingrid Glurich, John R. Schmelzer, Steven H. Yale, Humberto J. Vidaillet and James K. Burmester- Clinical Medicine & Research March 2007, 5 (1) 8;
- DOI: https://doi.org/10.3121/cmr.2007.724
-
Warfarin Initiation and the Potential Role of Genomic-Guided Dosing
Craig R. Lee- Clinical Medicine & Research November 2005, 3 (4) 205;
- DOI: https://doi.org/10.3121/cmr.3.4.205
-
Absence of Novel CYP4F2 and VKORC1 Coding Region DNA Variants in Patients Requiring High Warfarin Doses
James K. Burmester, Richard L. Berg, Ingrid Glurich, Steven H. Yale, John R. Schmelzer and Michael D. Caldwell- Clinical Medicine & Research November 2011, 9 (3-4) 119;
- DOI: https://doi.org/10.3121/cmr.2011.951
-
Absence of Novel CYP4F2 and VKORC1 Coding Region DNA Variants in Patients Requiring High Warfarin Doses
James K. Burmester, Richard L. Berg, Ingrid Glurich, Steven H. Yale, John R. Schmelzer and Michael D. Caldwell- Clinical Medicine & Research May 2011, cmr.2011.951;
- DOI: https://doi.org/10.3121/cmr.2011.951
-
Absence of Novel CYP4F2 and VKORC1 Coding Region DNA Variants in Patients Requiring High Warfarin Doses
James K. Burmester, Richard L. Berg, Ingrid Glurich, Steven H. Yale, John R. Schmelzer and Michael D. Caldwell- Clinical Medicine & Research May 2011, cmr.2011.951;
- DOI: https://doi.org/10.3121/cmr.2011.951
-
A Prospective, Randomized Pilot Trial of Model-Based Warfarin Dose Initiation using CYP2C9 Genotype and Clinical Data
Michael A. Hillman, Russell A. Wilke, Steven H. Yale, Humberto J. Vidaillet, Michael D. Caldwell, Ingrid Glurich, Richard L. Berg, John Schmelzer and James K. Burmester- Clinical Medicine & Research August 2005, 3 (3) 137;
- DOI: https://doi.org/10.3121/cmr.3.3.137
-
The Clinical Utility of Patient-Measured Blood Pressure at Home in the Management of Hypertension
Richard A. Dart- Clinical Medicine & Research August 2005, 3 (3) 134;
- DOI: https://doi.org/10.3121/cmr.3.3.134